End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.04 MXN | +2.28% | +2.22% | +20.34% |
Sales 2023 | 16.47B 976M | Sales 2024 * | 18.2B 1.08B | Capitalization | 15.84B 939M |
---|---|---|---|---|---|
Net income 2023 | 1.03B 61.1M | Net income 2024 * | 2.18B 129M | EV / Sales 2023 | 1.07 x |
Net Debt 2023 | 4.52B 268M | Net Debt 2024 * | 3.04B 180M | EV / Sales 2024 * | 1.04 x |
P/E ratio 2023 |
13.1
x | P/E ratio 2024 * |
7.75
x | Employees | 1,783 |
Yield 2023 |
1.38% | Yield 2024 * |
-
| Free-Float | 69.81% |
Latest transcript on Genomma Lab Internacional, S.A.B. de C.V.
1 day | +2.28% | ||
1 week | +2.22% | ||
Current month | +1.97% | ||
1 month | +10.22% | ||
3 months | +20.59% | ||
6 months | +17.60% | ||
Current year | +20.34% |
Managers | Title | Age | Since |
---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | - |
Founder | - | 96-10-29 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Burkhard Wittek
BRD | Director/Board Member | 70 | 18-04-17 |
Director/Board Member | - | - | |
Founder | - | 96-10-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 15 M€ | -1.62% | - | |
0.04% | 31 M€ | +5.93% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 117 M€ | +3.12% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 17.04 | +2.28% | 3,568,542 |
24-05-03 | 16.66 | -1.88% | 3,954,479 |
24-05-02 | 16.98 | +1.62% | 3,616,668 |
24-04-30 | 16.71 | +0.24% | 3,902,031 |
End-of-day quote Mexican S.E., May 05, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.34% | 910M | |
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- LAB B Stock